Influx Healthtech SME IPO: The SME initial public offering (IPO) of Influx Healthtech Limited opened for subscription on June 18, 2025, and will close on June 20, 2025. The healthcare-focused company aims to raise Rs 58.57 crore, comprising a fresh issue of Rs 48 crore and an offer for sale of up to 11,00,400 equity shares with a face value of Rs 10. Influx Healthtech has set the price band between Rs 91 and Rs 96 per share. Investors can apply for a minimum lot of 1,200 shares, amounting to an application value of Rs 1,15,200.
The IPO is a book-built issue and will be listed on the NSE SME platform.
Influx Healthtech SME IPO | Subscription Status Day 1
The IPO has received a strong response from investors across categories, with an overall subscription of 2.89 times so far on the first day bidding process.
The SME public issue witnessed a good response from investors in the first day bidding process, with the issue being subscribed 2.89 times overall so far.
A total of 8,310 applications have applied bid for 1.26 crore shares against the total issue size of 43,64,400 shares.
The retail individual investor (RII) segment led the demand, with 7,785 applications accounting for 93,42,000 shares, while the non-institutional investors (NIIs) submitted 523 applications for 20,88,000 shares.
Meanwhile, the qualified institutional buyers (QIBs) category saw 2 applications for 11,70,000 shares.
Influx Healthtech SME IPO | Allocation structure details
- For retail investors: 35 per cent
- For QIBs: 50 per cent
- For Niis: 15 per cent
Influx Healthtech financial performance
The company reported a revenue of Rs 104.99 crore in FY 2025 and a net profit of Rs 13.37 crore
Influx Healthtech SME IPO | Allotment, listing dates
Here is a summary of the important dates that should investors to remember as follows:
IPO Closing Date: Friday, June 20, 2025
Basis of Allotment: Monday, June 23, 2025
Initiation of Refunds & Credit of Shares: Tuesday, June 24, 2025
IPO Listing Date: Wednesday, June 25, 2025
What does Influx Healthtech do?
Founded in 2020, Influx Healthtech is a Mumbai-based Contract Development and Manufacturing Organisation (CDMO). The company specialises in manufacturing dietary and nutritional supplements, cosmetics, ayurvedic products, veterinary feed supplements, and homecare items. With manufacturing units located in Thane, Maharashtra, covering over 36,000 square feet, Influx Healthtech serves a wide range of clients including Bling Brands, Pursuit of Wellness, and BigFlex Lifescience.